http://www.w3.org/ns/prov#value | - Related information: www.abbvieinvestor.comAbbVie's long-term growth will be fueled by a compelling pipeline of more than 20 mid- to late-stage clinical programs ??? as well as new discoveries to address diseases including Hepatitis C, rheumatoid arthritis, psoriasis, multiple sclerosis, Alzheimer's disease, Parkinson's disease, spondyloarthropathies, multiple myeloma and endometriosis.
|